TPD52 as a Potential Prognostic Biomarker and its Correlation with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma: Bioinformatic Analysis and Experimental Verification.

Lu Miao Buze Chen Li Jing Tian Zeng Youguo Chen

Published in: Recent patents on anti-cancer drug discovery (2024)

TPD52 is upregulated in UCEC and may be a useful patent for prognostic biomarkers of UCEC, which may have important value for clinical treatment and supervision of UCEC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
endometrial cancer
combination therapy
climate change
patient reported
data analysis